SBIR-STTR Award

Implantable Stimulator For Preventing Aspiration
Award last edited on: 12/29/08

Sponsored Program
SBIR
Awarding Agency
NIH : NINDS
Total Award Amount
$100,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Dustin J Tyler

Company Information

Neurocontrol Corporation

38683 Taylor Parkway
North Ridgeville, OH 44035
   (440) 326-3800
   zipingfang@neurocontrol.com
   www.neurocontrol.com
Location: Single
Congr. District: 04
County: Lorain

Phase I

Contract Number: 1R43NS038776-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1999
Phase I Amount
$100,000
Severe swallowing deficits that result in aspiration occur in approximately 30% of stroke patients and are responsible for an estimated 40,000 deaths each year in the U.S. alone. For patients who cannot recover normal swallowing capabilities with standard rehabilitative exercises, irreversible surgical procedures that damage or destroy the larynx are the only remaining options. These surgeries are expensive and typically decrease the patient's quality of life. Recently, however, several animal studies have shown that electrical stimulation of the recurrent laryngeal nerve (RLN) can cause strong vocal cord adduction (VCA) and closure of the airway. The investigators propose RLN stimulation as an innovative, non- destructive technique for preventing aspiration. In Phase I, an existing implantable stimulation system will be adapted for RLN stimulation. Three post-stroke, chronically aspirating patients will be implanted with the RLN stimulation system and studied for three months. Standard clinical measurements of flexible fiberoptic laryngoscope visualization, methylene blue swallow tests, and modified barium swallow tests will be used to study RLN stimulation-induced VCA for preventing aspiration. This pilot study will demonstrate that RLN stimulation-induced VCA prevents aspiration, demonstrate the safety of the RLN stimulation, and identify essential design parameters for prototype device development in Phase II. PROPOSED COMMERCIAL APPLICATIONS: The proposed intervention is an innovative technique for treatment of aspiration. Annually, over 100,000 patients suffer from severe swallowing disorders that result in aspiration. Compared to available treatments, the proposed intervention is minimally invasive, improves patient quality of life, and reduces rehabilitation and care costs. Although initially focused on stroke-related aspiration, the treatment is also applicable to other central nervous system diseases that cause aspiration, such as Parkinson's disease, progressive supranuclear palsy, and brain tumors.

Public Health Relevance:
This Public Health Relevance is not available.

Thesaurus Terms:
Biomedical Equipment Development, Electronic Stimulator, Implant, Nervous System Prosthesis, Neuromuscular Stimulator, Swallowing Clinical Biomedical Equipment, Electrode, Laryngeal Nerve (X), Stroke, Vocal Cord Clinical Research, Gastrointestinal Visualization, Human Subject, Laryngoscopy, Medical Implant Science

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----